Outcome of patients with synchronous metastatic renal cell carcinoma treated with nivolumab and ipilimumab and the primary tumour in place

被引：0
|
作者：
Jurascheck, L. [1 ]
Van de Putte, Fransen E. [2 ]
Van den Brink, L. [3 ]
Van der Mijn, J. C. [4 ]
Wilgenhof, S. [4 ]
Van Thienen, J. V. [4 ]
Haanen, J. B. A. G. [4 ]
Boleti, E. [5 ]
Powles, T. [6 ]
Zondervan, P. J. [3 ]
Graafland, N. M. [2 ]
Bex, A. [1 ]
机构：
[1] Royal Free London NHS Fdn Trust, Dept Urol, London, England
[2] Netherlands Canc Inst, Dept Urol, Amsterdam, Netherlands
[3] Amsterdam UMC, Dept Urol, Amsterdam, Netherlands
[4] Netherlands Canc Inst, Dept Oncol, Amsterdam, Netherlands
[5] Royal Free NHS Fdn Trust, Dept Oncol, London, England
[6] Barts Canc Ctr, Dept Oncol, London, England
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0838
引用
收藏
页码：S1859 / S1860
页数：2
相关论文
共 50 条
  • [31] Radiomics can predict tumour response in patients treated with Nivolumab for a metastatic renal cell carcinoma: an artificial intelligence concept
    Zine‐Eddine Khene
    Romain Mathieu
    Benoit Peyronnet
    Romain Kokorian
    Anis Gasmi
    Fares Khene
    Nathalie Rioux-Leclercq
    Solène-Florence Kammerer-Jacquet
    Shahrokh Shariat
    Brigitte Laguerre
    Karim Bensalah
    World Journal of Urology, 2021, 39 : 3707 - 3709
  • [32] Radiomics can predict tumour response in patients treated with Nivolumab for a metastatic renal cell carcinoma: an artificial intelligence concept
    Khene, Zine-Eddine
    Mathieu, Romain
    Peyronnet, Benoit
    Kokorian, Romain
    Gasmi, Anis
    Khene, Fares
    Rioux-Leclercq, Nathalie
    Kammerer-Jacquet, Solene-Florence
    Shariat, Shahrokh
    Laguerre, Brigitte
    Bensalah, Karim
    WORLD JOURNAL OF UROLOGY, 2021, 39 (09) : 3707 - 3709
  • [33] Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
    Matsumura, Soichi
    Kato, Taigo
    Kujime, Yuma
    Kitakaze, Hiroaki
    Nakano, Kosuke
    Hongo, Sachiko
    Yoshioka, Iwao
    Okumi, Masayoshi
    Nonomura, Norio
    Takada, Shingo
    BMC UROLOGY, 2023, 23 (01)
  • [34] Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
    Soichi Matsumura
    Taigo Kato
    Yuma Kujime
    Hiroaki Kitakaze
    Kosuke Nakano
    Sachiko Hongo
    Iwao Yoshioka
    Masayoshi Okumi
    Norio Nonomura
    Shingo Takada
    BMC Urology, 23
  • [35] Changes of TCR repertoire in metastatic renal cell carcinoma and metastatic melanoma patients treated with nivolumab
    Klabusay, M.
    Skacel, J.
    Coupek, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [36] Clinical Activity of Ipilimumab Plus Nivolumab in Patients With Metastatic Non- Clear Cell Renal Cell Carcinoma
    Gupta, Ruby
    Ornstein, Moshe Chaim
    Li, Hong
    Allman, Kimberly D.
    Wood, Laura S.
    Gilligan, Timothy
    Garcia, Jorge A.
    Von Merveldt, Dendra
    Hammers, Hans J.
    Rini, Brian I.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (06) : 429 - 435
  • [37] Prognostic impact of FAN score in patients receiving nivolumab plus ipilimumab for metastatic renal cell carcinoma
    Yamashita, Shimpei
    Hamamoto, Shuzo
    Furukawa, Junya
    Fujita, Kazutoshi
    Takahashi, Masayuki
    Miyake, Makito
    Ito, Noriyuki
    Iwamoto, Hideto
    Kohjimoto, Yasuo
    Hara, Isao
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [38] Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors
    Gul, Anita
    Stewart, Tyler F.
    Mantia, Charlene M.
    Shah, Neil J.
    Gatof, Emily Stern
    Long, Ying
    Allman, Kimberly D.
    Ornstein, Moshe C.
    Hammers, Hans J.
    McDermott, David F.
    Atkins, Michael B.
    Hurwitz, Michael
    Rini, Brian I.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (27) : 3088 - +
  • [39] REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter Study
    Vauchier, Charles
    Auclin, Edouard
    Barthelemy, Philippe
    Carril-Ajuria, Lucia
    Ryckewaert, Thomas
    Borchiellini, Delphine
    Castel-Ajgal, Zahra
    Bennamoun, Mostefa
    Campedel, Luca
    Thiery-Vuillemin, Antoine
    Coquan, Elodie
    Crouzet, Laurence
    Berdah, Jean-Francois
    Chevreau, Christine
    Ratta, Raffaele
    Flechon, Aude
    Lefort, Felix
    Albiges, Laurence
    Gross-Goupil, Marine
    Vano, Yann-Alexandre
    Thibault, Constance
    Oudard, Stephane
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [40] Prognostic Impact of the Maximal Evaluable Lesion Size in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab Combination Therapy
    Mita, Yoshie
    Teishima, Jun
    Hara, Takuto
    Ueki, Hideto
    Wakita, Naoto
    Okamura, Yasuyoshi
    Suzuki, Kotaro
    Bando, Yukari
    Terakawa, Tomoaki
    Chiba, Koji
    Miyake, Hideaki
    INTERNATIONAL JOURNAL OF UROLOGY, 2025,
12345